Characterizing Hemorrhage in Acute Spinal Cord Injury With MRI
CHASM
1 other identifier
interventional
24
1 country
1
Brief Summary
The study is designed to determine whether hemorrhage within the injured spinal cord is influenced by mean arterial pressure (MAP) augmentation with vasopressors and by venous thromboembolism (VTE) prophylaxis with anticoagulants in the first two weeks following a traumatic spinal cord injury (tSCI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 6, 2021
CompletedFirst Submitted
Initial submission to the registry
February 12, 2021
CompletedFirst Posted
Study publicly available on registry
February 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedJuly 3, 2023
June 1, 2023
3.3 years
February 12, 2021
June 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Hemorrhage Quantification 1
Area of hematoma
Serial MRI assessments: Injury to 2 weeks post injury
Hemorrhage Quantification 2
Vertical length of hematoma and vertical length of cord edema
Serial MRI assessments: Injury to 2 weeks post injury
Hemorrhage Quantification 3
The point of maximum cord compression vertebral level and anatomic point of maximum cord compression vertebral sublevel
Serial MRI assessments: Injury to 2 weeks post injury
Hemorrhage Quantification 4
Vertical length of cord edema rostral to maximum compression and vertical length of cord edema caudal to maximum compression.
Serial MRI assessments: Injury to 2 weeks post injury
Secondary Outcomes (2)
Hemodynamic Management Assessment 1
Injury to 2 weeks post injury
Hemodynamic Management Assessment 2
Injury to 2 weeks post injury
Other Outcomes (1)
Neurologic Assessments
Injury to 6 months post injury
Study Arms (1)
Arm 1
EXPERIMENTALSerial MRI scans of patients with acute cervical SCI to quantify hemorrhage.
Interventions
Serial MRI scans of patients with acute cervical SCI to quantify hemorrhage.
Eligibility Criteria
You may qualify if:
- Acute tSCI injury involving bony spinal levels between C0 and T1
- Baseline Asia Impairment Scale (AIS) grade of A, B, or C
- Admission to study site within 24 hours of injury
- Male or female age 19 or older
- Able and willing to provide informed consent
You may not qualify if:
- Pathological fracture due to metabolic condition or neoplasia
- Spinal cord injury due to infection
- Presence of pacemaker, aneurysm clip or other device which is a contraindication to MRI
- BMI \> 40 and unable to fit within the MRI scanner
- Multiple life threatening injuries (ISS \>16) that make transport to MRI not in the patient's best interest
- Any condition that, at the time of admission, prevents a complete ISNCSCI assessment from being performed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vancouver General Hospital
Vancouver, British Columbia, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brian Kwon, MD
University of British Columbia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 12, 2021
First Posted
February 17, 2021
Study Start
February 6, 2021
Primary Completion
June 1, 2024
Study Completion
June 1, 2025
Last Updated
July 3, 2023
Record last verified: 2023-06